JPH04502323A - Ｃｃｋ作動薬用テトラペプチド誘導体 - Google Patents

Ｃｃｋ作動薬用テトラペプチド誘導体

Info

Publication number
JPH04502323A
JPH04502323A JP90501412A JP50141290A JPH04502323A JP H04502323 A JPH04502323 A JP H04502323A JP 90501412 A JP90501412 A JP 90501412A JP 50141290 A JP50141290 A JP 50141290A JP H04502323 A JPH04502323 A JP H04502323A
Authority
JP
Japan
Prior art keywords
asp
trp
phe
boc
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP90501412A
Other languages
English (en)
Japanese (ja)
Inventor
シオサキ，カズミ
ナドザン，アレツクス・エム
コペツカ，ハナ
シユー，ユー―コン
Original Assignee
アボツト・ラボラトリーズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アボツト・ラボラトリーズ filed Critical アボツト・ラボラトリーズ
Publication of JPH04502323A publication Critical patent/JPH04502323A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP90501412A 1988-12-21 1989-12-18 Ｃｃｋ作動薬用テトラペプチド誘導体 Pending JPH04502323A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28795588A 1988-12-21 1988-12-21
US287,955 1988-12-21
PCT/US1989/005673 WO1990006937A1 (fr) 1988-12-21 1989-12-18 Derives de tetrapeptides utilises comme agents reproduisant l'activite de la cck

Publications (1)

Publication Number Publication Date
JPH04502323A true JPH04502323A (ja) 1992-04-23

Family

ID=23105106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP90501412A Pending JPH04502323A (ja) 1988-12-21 1989-12-18 Ｃｃｋ作動薬用テトラペプチド誘導体

Country Status (5)

Country Link
EP (1) EP0449884A4 (fr)
JP (1) JPH04502323A (fr)
CA (1) CA2006189A1 (fr)
GR (1) GR890100827A (fr)
WO (1) WO1990006937A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914334A1 (en) * 1990-12-17 1992-06-17 Black James Foundation Tetrapeptide derivatives and analogues
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
FR2730998B1 (fr) * 1995-02-23 1997-04-04 Adir Nouveaux derives peptidiques agonistes de cholecystokinine
US6908900B2 (en) * 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
DE102006052755A1 (de) 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001720A1 (fr) * 1984-09-13 1986-03-27 Cytogen Corporation Conjugues d'agents therapeutiques-anticorps

Also Published As

Publication number Publication date
GR890100827A (el) 1991-03-15
CA2006189A1 (fr) 1990-06-21
EP0449884A4 (en) 1991-10-30
EP0449884A1 (fr) 1991-10-09
WO1990006937A1 (fr) 1990-06-28

Similar Documents

Publication Publication Date Title
JP5694320B2 (ja) Ａｐａｆ−１阻害剤化合物
JP5154609B2 (ja) Ｐｔｈ産生に対する被験物質の作用をアッセイする方法
TW482767B (en) Compounds with growth hormone releasing properties
TW515792B (en) N-alkanoylphenylalanine derivatives
US7989441B2 (en) Organic compounds
US5340802A (en) Peptide analog type-B CCK receptor ligands
US5559128A (en) 3-substituted piperidines promote release of growth hormone
ES2331102T3 (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
WO1995003277A1 (fr) Nouveau derive de pyrrolidine
JPH06293794A (ja) スルファモイル基およびアミジノ基を有する化合物、製造方法および医薬組成物
AU2003248456A1 (en) Substituted Piperidines as Melanocortin-4 Receptor Agonists
CA2433025A1 (fr) Piperidines/piperazines substituees utilisees comme agonistes du recepteur de melanocortine
JPH07507069A (ja) ヒトの心臓キマーゼを含むアンギオテンシンｉキマーゼに関する阻害剤
US5877182A (en) Piperidines promote release of growth hormone
TW200806610A (en) Compounds for the treatment of inflammatory disorders and microbial diseases
WO1989002431A1 (fr) Derives de l'acide d-glutamique et de l'acide d-aspartique
JPH0368597A (ja) コレシストキニンレセプターリガンドおよびその製法
CN104945470B (zh) 杂环构建的三肽环氧酮类化合物及制备和应用
PT94623A (pt) Processo de preparacao de antagonistas da colecistoquinina e de composicoes farmaceuticas que os contem
NO329899B1 (no) Propionsyrederivater som hemmer binding av integriner til deres reseptorer, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene til fremstilling av medikamenter
KR100318804B1 (ko) 티아졸릴-알라닌 잔기를 갖는 신규한 펩티드 유도체
da Costa et al. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds
US20060217362A1 (en) Novel compounds useful for bradykinin B1 receptor antagonism
JPH04502323A (ja) Ｃｃｋ作動薬用テトラペプチド誘導体
JPH06507402A (ja) 治療活性を有するα−置換ポリペプチド